Histiocytosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials
• Forums

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Conditions:   Langerhan's Cell Histiocytosis;   Juvenile Xanthogranuloma;   Erdheim-Chester Disease;   Rosai Dorfman Disease;   Neuro-Degenerative Disease;   Histiocytic Sarcoma;   Histiocytic Disorders, Malignant Intervention:   Drug: Cobimetinib Sponsors:   Carl Allen;   Texas Children's Hospital;   North American Consortium for Histiocytosis;   Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2019 Category: Research Source Type: clinical trials